Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immune Thrombocytopenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07700238
What this trial is testing

Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
Amgen 126
Very early researchNot Yet RecruitingNCT07416032
What this trial is testing

A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C)in Patients With Refractory Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 27
Large-scale testing (Phase 3)Looking for participantsNCT07233213
What this trial is testing

An Open-label Study of Intravenous Immunoglobulin (5%) for the Treatment of Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Grand Shuyang Life Sciences (Chengdu) Co., Ltd. 36
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07400250
What this trial is testing

Phase II Study of Orelabrutinib in Combination With Romiplostim N01 in Patients With Primary Immune Thrombocytopenia (ITP) Who Have Received At Least One Prior Line of Therapy

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Peking Union Medical College Hospital 28
Not applicableStudy completedNCT04902807
What this trial is testing

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

Who this might be right for
Autoimmune Lymphoproliferative SyndromeAutoimmune CytopeniaAutoimmune Diseases+17 more
Institut National de la Santé Et de la Recherche Médicale, France 325
Not applicableStudy completedNCT02042560
What this trial is testing

Study of Immune Thrombocytopenia Pathogenesis:

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Centre Hospitalier Universitaire Dijon 89
Testing effectiveness (Phase 2)Looking for participantsNCT06478537
What this trial is testing

TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination

Who this might be right for
Immune Thrombocytopenia
Peking Union Medical College Hospital 56
Testing effectiveness (Phase 2)Study completedNCT05279872
What this trial is testing

Zanubrutinib in Patients With ITP

Who this might be right for
Immune ThrombocytopeniaBruton Tyrosine Kinase
Peking University People's Hospital 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07669675
What this trial is testing

TPO-RA Plus Baricitinib vs. TPO-RA for ITP

Who this might be right for
ITP - Immune Thrombocytopenia
Peking University People's Hospital 100
Not applicableUnknownNCT04482777
What this trial is testing

IL37,Tlymphocytes,NK Cells in Pathogenesis of ITP

Who this might be right for
ITP
Assiut University 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07057778
What this trial is testing

Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP

Who this might be right for
Immune Thrombocytopenia (ITP)
Peking University People's Hospital 120
Testing effectiveness (Phase 2)Looking for participantsNCT07710248
What this trial is testing

SG301-SC Injection Safety Study in Subjects With Primary ITP Patients

Who this might be right for
Primary Immune Thrombocytopenia
Hangzhou Sumgen Biotech Co., Ltd. 60
Not applicableNot Yet RecruitingNCT07298733
What this trial is testing

The Value of Interleukin-1β and Interleukin-33 Genetic Expression in the Pathogenesis and Differentiation of Primary ITP and SLE-Related Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaSystem; Lupus Erythematosus
Sohag University 300
Large-scale testing (Phase 3)Looking for participantsNCT06722235
What this trial is testing

Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenic Purpura (ITP)
Takeda 171
Testing effectiveness (Phase 2)Ended earlyNCT03303950
What this trial is testing

Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis

Who this might be right for
AnemiaASXL1 Gene MutationEZH2 Gene Mutation+7 more
University of Utah 6
Post-approval studies (Phase 4)Study completedNCT03258866
What this trial is testing

The Study of Different Dose Rituximab in the Treatment of ITP

Who this might be right for
Purpura, Thrombocytopenic, IdiopathicImmune Thrombocytopenia
Shandong University 62
Large-scale testing (Phase 3)Study completedNCT01506414
What this trial is testing

Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP)

Who this might be right for
PurpuraIdiopathic Thrombocytopenic Purpura
Ming Hou 91
Post-approval studies (Phase 4)UnknownNCT03771378
What this trial is testing

Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 96
Testing effectiveness (Phase 2)Study completedNCT01965626
What this trial is testing

Randomized Open-label Study of Oseltamivir Combined With HD-DEX Versus HD-DEX in the Management of ITP

Who this might be right for
Thrombocytopenia
Shandong University 96
Next Page